Clinical Trial Update: GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GPC-3–targeted CAR T cells in adults with recurrent GPC-3–positive glioblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• GPC-3 CAR T cells (CAR T cells targeting glypican-3 (GPC-3))

Snippet

Sponsor: Baylor College of Medicine | Conditions: Glioblastoma Multiforme of Brain | Phase 1 | Status: RECRUITING